Biotech Investors Celebrating Deal Boom Can Thank Rough Quarter

(Bloomberg) -- Biotechnology investors popping corks at the slew of deals opening 2019 can thank a fourth-quarter slump for reigning in bloated valuations. And market watchers don’t see the volume ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.